| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Executive Chairman | Director
2 companies
Dugel Pravin is a See Remarks at Ocular Therapeutix, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $26.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | OCUL Ocular Therapeutix, Inc. | See Remarks | Sell | 20,056 | $8.28 | $166,063.68 | -0.7% | -2.3% | - | |
| Nov 24, 2025 | OCUL Ocular Therapeutix, Inc | See Remarks | Sell | 19,530 | $12.04 | $235,141.20 | -0.6% | -30.4% | - | |
| Aug 25, 2025 | OCUL Ocular Therapeutix, Inc | See Remarks | Sell | 21,494 | $12.04 | $258,787.76 | -0.7% | +1.9% | - | |
| May 23, 2025 | OCUL Ocular Therapeutix, Inc | See Remarks | Sell | 21,219 | $7.18 | $152,352.42 | -0.6% | +66.2% | +12.7% | |
| Feb 24, 2025 | OCUL Ocular Therapeutix, Inc | See Remarks | Sell | 21,475 | $6.87 | $147,533.25 | -0.6% | +3.3% | +33.3% | |
| Nov 25, 2024 | OCUL Ocular Therapeutix, Inc | See Remarks | Sell | 20,680 | $9.01 | $186,326.80 | -2.5% | -26.1% | +33.4% | |
| Aug 23, 2024 | OCUL Ocular Therapeutix, Inc | See Remarks | Sell | 20,880 | $9.02 | $188,337.60 | -2.5% | -6.5% | +35.0% | |
| May 23, 2024 | OCUL Ocular Therapeutix, Inc | See Remarks | Sell | 21,626 | $5.79 | $125,214.54 | -2.5% | +59.1% | +25.9% |